{"product_id":"the-end-of-alzheimers-the-first-program-to-prevent-and-reverse-cognitive-decline-paperback","title":"The End of Alzheimer's: The First Program to Prevent and Reverse Cognitive Decline - Paperback","description":"\u003cp\u003eby \u003cb\u003eDale Bredesen\u003c\/b\u003e (Author)\u003c\/p\u003e\u003cp\u003e\u003cb\u003eThe instant \u003ci\u003eNew York Times\u003c\/i\u003e and \u003ci\u003eWall Street Journal\u003c\/i\u003e bestseller \u003c\/b\u003e\u003c\/p\u003e\u003cp\u003e\u003c\/p\u003eA groundbreaking plan to prevent and reverse Alzheimer's Disease that fundamentally changes how we understand cognitive decline. \u003cp\u003e\u003c\/p\u003e Everyone knows someone who has survived cancer, but until now no one knows anyone who has survived Alzheimer's Disease. \u003cp\u003e\u003c\/p\u003e In this paradigm shifting book, Dale Bredesen, MD, offers real hope to anyone looking to prevent and even reverse Alzheimer's Disease and cognitive decline. Revealing that AD is not one condition, as it is currently treated, but three, \u003ci\u003eThe End of Alzheimer's\u003c\/i\u003e outlines 36 metabolic factors (micronutrients, hormone levels, sleep) that can trigger \"downsizing\" in the brain. The protocol shows us how to rebalance these factors using lifestyle modifications like taking B12, eliminating gluten, or improving oral hygiene. \u003cp\u003e\u003c\/p\u003e The results are impressive. Of the first ten patients on the protocol, nine displayed significant improvement with 3-6 months; since then the protocol has yielded similar results with hundreds more. Now, \u003ci\u003eThe End of Alzheimer's\u003c\/i\u003e brings new hope to a broad audience of patients, caregivers, physicians, and treatment centers with a fascinating look inside the science and a complete step-by-step plan that fundamentally changes how we treat and even think about AD.\u003ch3\u003eAuthor Biography\u003c\/h3\u003e\u003cp\u003e\u003cb\u003eDale Bredesen, M.D., \u003c\/b\u003eis internationally recognized as an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease. He graduated from Caltech, then earned his M.D. from Duke University Medical Center in Durham, North Carolina. He served as chief resident in neurology at the University of California, San Francisco (UCSF) before joining Nobel laureate Stanley Prusiner's laboratory at UCSF as an NIH postdoctoral fellow. He held faculty positions at UCSF, UCLA, and the University of California, San Diego. Dr. Bredesen directed the Program on Aging at the Burnham Institute before coming to the Buck Institute in 1998 as its founding president and CEO. He is the chief medical officer of MPI Cognition.\u003c\/p\u003e\u003cdiv\u003e\n\u003cstrong\u003eNumber of Pages:\u003c\/strong\u003e 320\u003c\/div\u003e\u003cdiv\u003e\n\u003cstrong\u003eDimensions:\u003c\/strong\u003e 0.9 x 7.9 x 5.3 IN\u003c\/div\u003e\u003cdiv\u003e\n\u003cstrong\u003ePublication Date:\u003c\/strong\u003e July 21, 2020\u003c\/div\u003e","brand":"Books by splitShops","offers":[{"title":"Default Title","offer_id":51759935095072,"sku":"9780735216211","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0974\/9764\/5344\/files\/41124b0d020d42f4682279c0a718ee12.webp?v=1780166624","url":"https:\/\/ebocreations.com\/products\/the-end-of-alzheimers-the-first-program-to-prevent-and-reverse-cognitive-decline-paperback","provider":"The E-Book Oasis LLC","version":"1.0","type":"link"}